Search results
Octant, a clinical stage drug discovery company, has recently announced the dosing of the first healthy volunteer in their Phase 1a clinical trial of OCT-980 for Rhodopsin-associated autosomal dominant Retinitis Pigmentosa (RHO-adRP).
On a typical week in the stem cell lab there are many different experiments going on. Different people work on their individual projects, but we often collaborate to share ideas and help each other.
The latest research news from Retina UK.
Retina UK aims not only to progress research along established threads, but to stimulate new thinking, encourage innovative approaches and nurture original ideas.
Information for healthcare professionals: Genetic testing and counselling in inherited retinal disease
Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.
Thank you to all those who completed our recent Sight Loss Survey – almost 700 of you took the time to share your experiences.
The team have found the cause of disease in the first ever family tree drawn up at Moorfields Eye Hospital over 35 years ago, which had remained unsolved until now.
Inside: Our intrepid Sahara Trek #TeamRetinaUK tell us about their incredible experience. 2026 is now fully underway and we are excited to tell you about our plans. Could you take part in a challenge event or volunteer to do a bucket collection in London for Retina UK?
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
